The European drugs market is growing in scale and complexity
EU Drug Markets Analysis: Key insights for policy and practice - EUDA
Industrial-scale production of cannabis and synthetic drugs, such as amphetamine, methamphetamine, MDMA and cathinones, takes place in the EU for both domestic ...
The European drugs market is growing in scale and complexity
Asset recovery: Despite comprehensive legislation on money laundering in EU Member States, the number of assets and proceeds successfully ...
EU Drug Markets Analysis 2024 - EUDA - European Union
The scale and complexity of synthetic drug production in Europe is driven by ... However, the landscape of Europe's opioid problem is evolving and growing in ...
EU Drug Markets Analysis 2024 Key insights for policy and practice
The scale and complexity of synthetic drug production in Europe is driven by innovation in methods and equipment, and the availability of the key chemicals ...
EUROPEAN DRUG REPORT 2023: HIGHLIGHTS - drogy-info.cz
Drug availability remains high across all substance types and the scale and complexity of illicit drug production within Europe continue to grow ...
key developments (European Drug Report 2024) | Sante.lu
... scale and complexity of illicit drug production within Europe is continuing to grow. ... scale production for both European and external markets ...
EMCDDA-Europol Launch: EU Drug Markets - YouTube
The speakers will discuss the continued adaptation of the NPS market and increasing integration with the market for established controlled drugs ...
IN FOCUS CHANGES IN DRUG MARKETS
Polydrug trafficking, i.e. trafficking in more than one drug, and its potential growth, definitely con- tributes to the growing complexity of drug markets as ...
The increasing organisational and technical complexity, interconnectedness and ... Although some large-scale cultivation takes place outdoors, intensive.
Key insights for policy and practice (EMCDDA-Europol) - YouTube
On 7 March, the EMCDDA and Europol held an online press conference to launch 'EU Drug Markets: Key insights for policy and practice', ...
Shifting drug markets in North America - a global crisis in the making?
Understanding drug market dynamics and their underlying driving factors is paramount to developing effective responses to the overdose ...
Emerging from disruption: The future of pharma operations strategy
The pharma industry is facing a multitude of challenging trends (Exhibit 1). Global demand is growing rapidly, and the unprecedented need for ...
Research and Development in the Pharmaceutical Industry
The share of revenues that drug companies devote to R&D has also grown: On average, pharmaceutical companies spent about one-quarter of their ...
GLOBAL OVERVIEW: DRUG DEMAND DRUG SUPPLY
synthetic opioids impacting the recreational drug market”. 101 UNODC, World Drug Report 2020, “The growing complexity of the opioid crisis”. 102 Nick ...
European drug markets worth €30 billion - Russell Webster
Europeans are spending at least EUR 30 billion on drugs each year at retail level, making the drug market a major source of income for organised crime groups ...
Pharma trends 2024: Shaping the future landscape | ZS
A coming (r)evolution? Pharma industry outlook, trends and strategies for 2024 ... A trio of outside forces will test the pharmaceutical ...
medicines as 'opportunists', eroding the market share of incumbent manufacturers of branded products.1 As a result, generic market growth in Europe lagged ...
The EU's endless drug shortage, its fragile supply chains ... - ING Think
This fragility, along with increasing global demand and lower prices in Europe than in the US, explains the persistent drug scarcity in Europe.
Shifting North American drug markets and challenges for the system ...
... scale macroeconomic conditions of drug markets as well as the behavioural economics of individual substance use. It is important for policy ...
Review of drugs: summary (accessible version) - GOV.UK
... complex and overlapping markets for illegal drugs. I took a ... cocaine market and the increasing role of young people in drug supply.